Growth Metrics

TrueBlue (TBI) Liabilities and Shareholders Equity (2016 - 2025)

TrueBlue (TBI) has disclosed Liabilities and Shareholders Equity for 17 consecutive years, with $690.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 1.69% to $690.5 million in Q3 2025 year-over-year; TTM through Dec 2025 was $690.5 million, a 67.14% decrease, with the full-year FY2024 number at $675.4 million, down 24.91% from a year prior.
  • Liabilities and Shareholders Equity was $690.5 million for Q3 2025 at TrueBlue, up from $675.4 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.0 billion in Q4 2021 to a low of $675.4 million in Q4 2024.
  • A 5-year average of $883.6 million and a median of $919.9 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: increased 12.74% in 2021, then decreased 24.91% in 2024.
  • TrueBlue's Liabilities and Shareholders Equity stood at $1.0 billion in 2021, then decreased by 1.34% to $1.0 billion in 2022, then dropped by 11.77% to $899.4 million in 2023, then fell by 24.91% to $675.4 million in 2024, then increased by 2.24% to $690.5 million in 2025.
  • Per Business Quant, the three most recent readings for TBI's Liabilities and Shareholders Equity are $690.5 million (Q3 2025), $675.4 million (Q4 2024), and $702.4 million (Q3 2024).